Paracetamol oral liquid: Brand change

Brand change Access change Active

From 1 September 2022, we have listed a temporary new brand of paracetamol liquid.

Pamol brand paracetamol 250 mg per 5 ml listed from 1 November 2022

From 1 November 2022, Pamol is listed as the 250 mg per 5 ml oral liquid paracetamol. We are advised that there is still ample stock of Paracare Double Strength 250 mg per 5 ml available in the 1 litre bottle.

Wholesalers may request that this stock is used before the new Pamol product is released. Pharmacists can still claim dispensing of Paracare Double Strength. It will remain funded until 1 April 2023.

New Pamol Bottle. The label is in black and white, and has PAMOL in large block letters on the front. It is a different from the Pamol you can buy..
New Pamol glass bottle

Key differences from Paracare Double Strength

Pamol 250 mg per 5 ml:

  • A smaller pack size, 1000 ml to 200 ml, glass bottles with a child-resistant cap
  • A change in colour from orange to colour-free
  • Remains orange flavour
  • Alcohol and sugar free

Pamol is orange in flavour, the same as the currently funded 250 mg per 5 ml strength paracetamol oral liquid, Paracare Double Strength.

Package size change

Dispensing data suggests that 200 ml is the most common amount dispensed. As such, changing to a 200 ml pack size means most dispensing can be in the original packaging. This will allow paracetamol oral liquid to be dispensed with clear strength information, which will reduce the chance of dispensing errors in the pharmacy and result in less confusion for people using this medicine.

Colour free warning

Both strengths of paracetamol oral liquid, as well as the currently funded ibuprofen liquid, are colour free. When prescribing and dispensing, this similarity may need to be specifically highlighted to patients, whānau or caregivers.

Consumer information 

A pamphlet for consumers explaining the change should be available shortly. We will add it to this page as soon as it is available, along with translations.

Translations

Te reo Māori(external link)

Samoan(external link)

Tongan(external link)

Chinese (simplified)(external link)

Cook Islands Māori(external link)

Avallon temporary 120 mg brand

Supplies of Paracare 120 mg are exhausted. To cover the gap before the new contracted brand enters the market in January 2023, we’ve listed the Avallon brand.

From 1 September 2022, we’ve listed the following brands of  paracetamol oral liquid:

  • Paracetamol 120 mg per 5 ml (200 ml) – Avallon (Pharmacode 2643138)

Key differences of Avallon

  • Flavour is strawberry-vanilla for both strengths (previously strawberry and orange)
  • Colour is off-white for both strengths (previously pink and orange)
  • A smaller pack size, 200 ml glass bottles with a child-resistant cap

Translations of the pamphlet

Te Reo Māori [PDF](external link)

Samoan [PDF](external link) 

Tongan [PDF](external link)

Chinese (Simplified) [PDF](external link)

Cook Island Māori [PDF](external link)

Medsafe approval status 

The 120 mg product has Medsafe approval. The supplier, Noumed, has also applied to Medsafe for provisional approval of the 240 mg presentation. We will update the website when it is approved.  

Prescribing and dispensing restrictions remain

Restrictions will continue for these temporary brands to ensure everyone who needs paracetamol liquid can access this medicine. We apologise for any inconvenience this may cause.

The restrictions are:

  • A maximum of 600 ml liquid paracetamol can be prescribed per prescription. Patients with long-term conditions who need regular daily dosing can be prescribed quantities greater than 600 ml by endorsement.
  • A maximum of 200 ml can be dispensed for non-endorsed patients, dispensed by repeat dispensing if the amount prescribed exceeds 200 ml. 

Why are these restrictions in place?

There is significant demand here and around the world for paracetamol to help manage the symptoms of COVID-19. 

To ensure there is enough oral paracetamol for everyone who needs it, we have limited the amount anyone can be prescribed or dispensed. 

We acknowledge that these changes may inconvenience some regular users of oral paracetamol.  

Long-term supply of paracetamol oral liquid

We have secured long-term supply of paracetamol oral liquid through our tender process. 

  • From 1 November 2022, the funded brand of paracetamol 250 mg per 5 ml oral liquid will be Pamol.
  • From 1 January 2023, the funded brand of paracetamol 120 mg per 5 ml oral liquid will be Paracetamol (Ethics).  

The new brands will have the same flavours as the Paracare brand,   strawberry for the lower strength and orange for the higher strength. Both strengths will be colour-free, supplied with a child-resistant cap, and come in 200 ml bottles. 

Key dates

1 June 2022 - Prescribing and dispensing restrictions began

1 September 2022 – Avallon brand paracetamol listed

September 2022 – Supplies of Paracare brand paracetamol likely depleted.

1 November 2022 - Pamol brand paracetamol 250 mg per 5 ml oral liquid listed

1 January 2023 - Paracetamol (Ethics) brand paracetamol 120 mg per 5 ml oral liquid listed

1 April 2023 - Paracare Double Strength 250 mg per 5 ml oral liquid (pharmacode 306088) delisted

1 June 2023 - Paracare 120 mg per 5 ml oral liquid (pharmacode 304905) delisted

TBC – Avallon brand paracetamols will be delisted later, to allow time for any stock to be dispensed.

Who to contact

We welcome feedback on these changes, email enquiry@pharmac.govt.nz